🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. Paracetamol

    United Therapeutics Europe Ltd

    Blood Pressure

    approved small molecule completed

    1 trial

  2. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial

  3. Peginterferon alfa

    Third Affiliated Hospital, Sun Yat-Sen University

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  4. Peginterferon alfa-2a

    Vera Therapeutics

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  5. Pegyinterferon-alfa-2a

    Chinese University of Hong Kong

    Chronic Hepaititis B

    approved small molecule completed

    1 trial

  6. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  7. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  8. Pentocur 1 g pulver till injektionsvätska, lösning

    The George Institute

    Major depressive disorder

    approved small molecule active

    1 trial

  9. Perflutren lipid

    United Therapeutics Europe Ltd

    Acute Spinal Cord Injury

    approved small molecule active

    1 trial

  10. Perineural infusion [continuous peripheral nerve block(s)]

    United Therapeutics Europe Ltd

    Phantom Limb Pain

    approved small molecule completed

    1 trial

  11. Pertussis containing vaccine

    United Therapeutics Europe Ltd

    Pregnancy Related

    approved mab active

    1 trial

  12. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  13. Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  14. Pharmacotherapy

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule active

    1 trial

  15. Phenylephrine

    United Therapeutics Europe Ltd

    Spinal Anesthesia

    approved small molecule terminated

    1 trial

  16. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  17. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  18. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  19. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  20. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  21. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

  22. Pioglitazone and Metformin

    Disc Medicine

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  23. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials

  24. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources